Logo image of XYLO

XYLO TECHNOLOGIES LTD (XYLO) Stock Fundamental Analysis

USA - NASDAQ:XYLO - US58471G5080 - ADR

5.07 USD
0 (0%)
Last: 8/21/2025, 8:00:02 PM
5.29 USD
+0.22 (+4.34%)
After Hours: 8/14/2025, 8:00:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to XYLO. XYLO was compared to 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of XYLO have multiple concerns. XYLO has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year XYLO has reported negative net income.
In the past year XYLO has reported a negative cash flow from operations.
XYLO Yearly Net Income VS EBIT VS OCF VS FCFXYLO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

The Return On Assets of XYLO (-16.05%) is comparable to the rest of the industry.
The Return On Equity of XYLO (-33.51%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -16.05%
ROE -33.51%
ROIC N/A
ROA(3y)-17.06%
ROA(5y)N/A
ROE(3y)-42.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XYLO Yearly ROA, ROE, ROICXYLO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

With a Gross Margin value of 22.38%, XYLO is not doing good in the industry: 78.01% of the companies in the same industry are doing better.
XYLO's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for XYLO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.16%
GM growth 5YN/A
XYLO Yearly Profit, Operating, Gross MarginsXYLO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

XYLO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XYLO has more shares outstanding
XYLO has a worse debt/assets ratio than last year.
XYLO Yearly Shares OutstandingXYLO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 500K 1M 1.5M
XYLO Yearly Total Debt VS Total AssetsXYLO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -3.16, we must say that XYLO is in the distress zone and has some risk of bankruptcy.
XYLO has a Altman-Z score of -3.16. This is in the lower half of the industry: XYLO underperforms 64.40% of its industry peers.
XYLO has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
XYLO has a better Debt to Equity ratio (0.07) than 63.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -3.16
ROIC/WACCN/A
WACC8.8%
XYLO Yearly LT Debt VS Equity VS FCFXYLO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

XYLO has a Current Ratio of 1.14. This is a normal value and indicates that XYLO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.14, XYLO is not doing good in the industry: 84.82% of the companies in the same industry are doing better.
XYLO has a Quick Ratio of 1.14. This is a normal value and indicates that XYLO is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of XYLO (1.14) is worse than 70.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
XYLO Yearly Current Assets VS Current LiabilitesXYLO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

XYLO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.37%, which is quite impressive.
The Revenue for XYLO has decreased by -67.45% in the past year. This is quite bad
Measured over the past years, XYLO shows a very strong growth in Revenue. The Revenue has been growing by 43.44% on average per year.
EPS 1Y (TTM)66.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.26%
Revenue 1Y (TTM)-67.45%
Revenue growth 3Y43.44%
Revenue growth 5YN/A
Sales Q2Q%-72.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y1216.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XYLO Yearly Revenue VS EstimatesXYLO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
XYLO Yearly EPS VS EstimatesXYLO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 5 -5 -10 -15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XYLO. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 0.79, the valuation of XYLO can be described as very cheap.
Based on the Price/Forward Earnings ratio, XYLO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.82. XYLO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 0.79
XYLO Price Earnings VS Forward Price EarningsXYLO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XYLO Per share dataXYLO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

XYLO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XYLO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XYLO TECHNOLOGIES LTD

NASDAQ:XYLO (8/21/2025, 8:00:02 PM)

After market: 5.29 +0.22 (+4.34%)

5.07

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.07%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.61M
Revenue(TTM)29.86M
Net Income(TTM)-6027000
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.79
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 2.99
EV/EBITDA N/A
EPS(TTM)-3.46
EYN/A
EPS(NY)6.45
Fwd EY127.15%
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.96
OCFYN/A
SpS15.76
BVpS9.49
TBVpS1.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.05%
ROE -33.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.38%
FCFM N/A
ROA(3y)-17.06%
ROA(5y)N/A
ROE(3y)-42.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.32%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z -3.16
F-Score4
WACC8.8%
ROIC/WACCN/A
Cap/Depr(3y)15.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.26%
EPS Next Y1216.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-67.45%
Revenue growth 3Y43.44%
Revenue growth 5YN/A
Sales Q2Q%-72.47%
Revenue Next Year5.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.8%
OCF growth 3YN/A
OCF growth 5YN/A

XYLO TECHNOLOGIES LTD / XYLO FAQ

What is the fundamental rating for XYLO stock?

ChartMill assigns a fundamental rating of 2 / 10 to XYLO.


What is the valuation status for XYLO stock?

ChartMill assigns a valuation rating of 4 / 10 to XYLO TECHNOLOGIES LTD (XYLO). This can be considered as Fairly Valued.


Can you provide the profitability details for XYLO TECHNOLOGIES LTD?

XYLO TECHNOLOGIES LTD (XYLO) has a profitability rating of 1 / 10.


How financially healthy is XYLO TECHNOLOGIES LTD?

The financial health rating of XYLO TECHNOLOGIES LTD (XYLO) is 2 / 10.


Can you provide the expected EPS growth for XYLO stock?

The Earnings per Share (EPS) of XYLO TECHNOLOGIES LTD (XYLO) is expected to grow by 1216.67% in the next year.